These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21781236)

  • 41. Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B.
    Nichols TC; Raymer RA; Franck HW; Merricks EP; Bellinger DA; DeFriess N; Margaritis P; Arruda VR; Kay MA; High KA
    Haemophilia; 2010 May; 16 Suppl 3(Suppl 3):19-23. PubMed ID: 20586797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy - are we ready now?
    Kaczmarek R
    Haemophilia; 2022 May; 28 Suppl 4(Suppl 4):35-43. PubMed ID: 35521736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Immune Response to the fVIII Gene Therapy in Preclinical Models.
    Patel SR; Lundgren TS; Spencer HT; Doering CB
    Front Immunol; 2020; 11():494. PubMed ID: 32351497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adeno-associated viral vectors for the treatment of hemophilia.
    High KA; Anguela XM
    Hum Mol Genet; 2016 Apr; 25(R1):R36-41. PubMed ID: 26614390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The critical need for postmarketing surveillance in gene therapy for haemophilia.
    Konkle BA; Recht M; Hilger A; Marks P
    Haemophilia; 2021 Feb; 27 Suppl 3():126-131. PubMed ID: 32495492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effective gene therapy for hemophilia, at last…].
    Jordan B
    Med Sci (Paris); 2018 Mar; 34(3):267-274. PubMed ID: 29547114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A; Zweier-Renn LA; Hawley RG
    Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.
    McCORMACK WM; Seiler MP; Bertin TK; Ubhayakar K; Palmer DJ; Ng P; Nichols TC; Lee B
    J Thromb Haemost; 2006 Jun; 4(6):1218-1225. PubMed ID: 16706963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemophilia gene therapy-New country initiatives.
    Reiss UM; Zhang L; Ohmori T
    Haemophilia; 2021 Feb; 27 Suppl 3():132-141. PubMed ID: 32638467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic gene therapy for haemophilia B.
    Kay MA
    Haemophilia; 1998 Jul; 4(4):389-92. PubMed ID: 9873759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in gene therapy for hemophilia: basis, current status, and future perspectives.
    Ohmori T
    Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Genetic therapy for hemophiliacs--therapeutic potential and technological limits].
    Michou AI; Christ M; Pavirani A; Mehtali M
    Transfus Clin Biol; 1997; 4(3):251-61. PubMed ID: 9264782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina.
    Montgomery RR; Monahan PE; Ozelo MC
    Haemophilia; 2010 Jul; 16 Suppl 5(Suppl 5):29-34. PubMed ID: 20590853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene therapy for haemophilia...yes, but...with non-viral vectors?
    Liras A; Olmedillas S
    Haemophilia; 2009 May; 15(3):811-6. PubMed ID: 19432929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral vector-mediated gene therapy for hemophilia.
    VandenDriessche T; Collen D; Chuah MK
    Curr Gene Ther; 2001 Sep; 1(3):301-15. PubMed ID: 12109144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AAV-based neonatal gene therapy for hemophilia A: long-term correction and avoidance of immune responses in mice.
    Hu C; Lipshutz GS
    Gene Ther; 2012 Dec; 19(12):1166-76. PubMed ID: 22241178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AAV-mediated gene transfer for treatment of hemophilia.
    Wang L; Herzog RW
    Curr Gene Ther; 2005 Jun; 5(3):349-60. PubMed ID: 15975012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemophilia gene therapy: ushering in a new treatment paradigm?
    George LA
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):226-233. PubMed ID: 34889378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
    Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
    J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.